Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  143 results for ""GLUCAGON-like peptide-1 receptor""

Your Filters

Publication : acta diabetologica Filter by : Keyword
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes.

  • Authors : Ciardullo S; Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Milan, Italy. .; Department of Medicine and Rehabilitation, Policlinico di Monza, Via Modigliani 10, 20900, Monza, Italy. .

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Receptors, Gastrointestinal Hormone*/Receptors, Gastrointestinal Hormone*/Receptors, Gastrointestinal Hormone*/agonists

  • Source: Acta diabetologica [Acta Diabetol] 2024 Aug; Vol. 61 (8), pp. 941-950. Date of Electronic Publication: 2024 Jun 03.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Glucagon-like peptide-1 receptor agonists (GLP1-RA) in the treatment of mitochondrial diabetes.

  • Authors : Lebbar M; Department of Endocrinology and Diabetes, Hospices Civils de Lyon, Lyon, France.; Timsit J

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucagon-Like Peptide-1 Receptor*; DNA, Mitochondrial

  • Source: Acta diabetologica [Acta Diabetol] 2021 Sep; Vol. 58 (9), pp. 1281-1282. Date of Electronic Publication: 2021 May 05.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Usefulness of circulating EPAC1 as biomarkers of therapeutic response to GLP-1 receptor agonists.

  • Authors : Hernández C; Department of Endocrinology, Vall d'Hebron University Hospital, Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Diabetes Y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain.

Subjects: Diabetes Mellitus, Type 2* ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists; Biomarkers

  • Source: Acta diabetologica [Acta Diabetol] 2022 Nov; Vol. 59 (11), pp. 1437-1442. Date of Electronic Publication: 2022 Aug 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials.

  • Authors : Dicembrini I; Diabetology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Via delle Oblate 4, 50141, Florence, Italy.; Nreu B

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use

  • Source: Acta diabetologica [Acta Diabetol] 2017 Oct; Vol. 54 (10), pp. 933-941. Date of Electronic Publication: 2017 Jul 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials.

  • Authors : Monami M; Diabetology, Careggi Teaching Hospital, Azienda Ospedaliero-Universitaria Careggi, Via delle Oblate 4, 50141, Florence, Italy. .; Dicembrini I

Subjects: Biomarkers, Pharmacological/Biomarkers, Pharmacological/Biomarkers, Pharmacological/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*epidemiology

  • Source: Acta diabetologica [Acta Diabetol] 2017 Dec; Vol. 54 (12), pp. 1101-1114. Date of Electronic Publication: 2017 Sep 20.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis.

  • Authors : Jin Y; Department of Internal Medicine, Hebei Medical University, Shijiazhuang, 050017, Hebei, People's Republic of China.; Endocrinology Department, Hebei General Hospital, Shijiazhuang, 050051, Hebei, People's Republic of China.

Subjects: Cognition/Cognition/Cognition/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use

  • Source: Acta diabetologica [Acta Diabetol] 2020 Oct; Vol. 57 (10), pp. 1129-1144. Date of Electronic Publication: 2020 Apr 16.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Trend 2010-2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast Italy.

  • Authors : Fadini GP; Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy. .; Division of Metabolic Diseases, Padova Hospital, 35128, Padua, Italy. .

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*administration & dosage

  • Source: Acta diabetologica [Acta Diabetol] 2020 Mar; Vol. 57 (3), pp. 367-375. Date of Electronic Publication: 2019 Oct 31.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis.

Subjects: *GLUCAGON-like peptide-1 receptor; *NLRP3 protein; *GLUCAGON-like peptide-1 agonists

  • Source: Acta Diabetologica. Feb2024, Vol. 61 Issue 2, p225-234. 10p.

Record details

Read More Add to Saved list
×
Academic Journal

Species differences in pancreatic binding of DO3A-VS-Cys 40 -Exendin4.

  • Authors : Eriksson O; Department of Medicinal Chemistry, Uppsala University, Dag Hammarskjölds väg 14C, 3tr, SE-751 83, Uppsala, Sweden. .; Rosenström U

Subjects: Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*metabolism ; Heterocyclic Compounds, 1-Ring/Heterocyclic Compounds, 1-Ring/Heterocyclic Compounds, 1-Ring/*pharmacokinetics ; Insulin-Secreting Cells/Insulin-Secreting Cells/Insulin-Secreting Cells/*metabolism

  • Source: Acta diabetologica [Acta Diabetol] 2017 Nov; Vol. 54 (11), pp. 1039-1045. Date of Electronic Publication: 2017 Sep 11.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach.

  • Authors : Crisci I; Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Nuovo Ospedale Santa Chiara, Via Paradisa, 2, 56124, Pisa, Italy.; Aragona M

Subjects: Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use

  • Source: Acta diabetologica [Acta Diabetol] 2015 Dec; Vol. 52 (6), pp. 1129-33. Date of Electronic Publication: 2015 Aug 21.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  143 results for ""GLUCAGON-like peptide-1 receptor""